Details for New Drug Application (NDA): 211285
✉ Email this page to a colleague
NDA 211285 describes PROGESTERONE, which is a drug marketed by Amneal Pharms Ny, Bionpharma, Dr Reddys, Eugia Pharma, Sofgen Pharms, Teva Pharms, Xiromed, Accord Hlthcare, Actavis Labs Ut Inc, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, and Lilly, and is included in fifteen NDAs. It is available from twenty-one suppliers. Additional details are available on the PROGESTERONE profile page.
The generic ingredient in PROGESTERONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
The generic ingredient in PROGESTERONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
Summary for 211285
| Tradename: | PROGESTERONE |
| Applicant: | Eugia Pharma |
| Ingredient: | progesterone |
| Patents: | 0 |
Suppliers and Packaging for NDA: 211285
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PROGESTERONE | progesterone | CAPSULE;ORAL | 211285 | ANDA | A-S Medication Solutions | 50090-5928 | 50090-5928-0 | 10 CAPSULE in 1 BOTTLE (50090-5928-0) |
| PROGESTERONE | progesterone | CAPSULE;ORAL | 211285 | ANDA | A-S Medication Solutions | 50090-5928 | 50090-5928-1 | 90 CAPSULE in 1 BOTTLE (50090-5928-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Oct 26, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
| Approval Date: | Oct 26, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
